Sage Journals: Discover world-class research

Retricted access

Review article

First published 2022-10

Rucaparib and olaparib for the treatment of prostate cancer: A clinician's guide to choice of therapy

Sidney Veach Keisner

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2021-9

Olaparib attenuates sepsis-induced acute multiple organ injury via ERK-mediated CD14 expression

Zhixia Chen, Yihui Chen, Xianwei Jin [...]

Experimental Biology and Medicine

Open access

Research article

First published 2024

Improving olaparib exposure to optimize adverse effects management

Marylise Sterlé, Alicja Puszkiel, Chloé Burlot [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2019

Severe haematological toxicities in relapsed ovarian cancer treated with olaparib or niraparib: an Italian cost-minimization analysis

Carlo Lazzaro, Nicola Amedeo Mazzanti, Fabio Parazzini

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open access

Case report

First published 2024

Promising Response of Olaparib in Patient With Germline ATM -Mutated Metastatic Gastric Cancer

Kok Hoe Chan, Darius Rutazanaa, Curtis Wray [...]

Journal of Investigative Medicine High Impact Case Reports

Open access

Review article

First published 2019

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer

Jonathan A. Ledermann, Eric Pujade-Lauraine

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2020-6

Pharmacological issues concerning olaparib capsule and tablet formulations in treating ovarian cancer: Are they really the same drug?

Gianluca Perego, Renata Nozza, Emanuela Oggionni [...]

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2021

Olaparib in hormone receptor-positive,HER2-negative metastatic breast cancer with a somatic BRCA2 mutation

Lee S. Schwartzberg, Lesli A. Kiedrowski

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2021-6

Enhancing the sensitivity of ovarian cancer cells to olaparib via microRNA-20b-mediated cyclin D1 targeting

Qian Zhong, Ying Xiong, Chen Ling [...]

Experimental Biology and Medicine

Open access

Research article

First published 2017-10

The expression of APE1 in triple-negative breast cancer and its effect on drug sensitivity of olaparib

Tianran Chen, Chuan Liu, Heng Lu [...]

Tumor Biology

Search results